Using detection of survivin-expressing circulating tumor cells in peripheral blood to predict tumor recurrence following curative resection of gastric cancer

Journal of Surgical Oncology

Volumn 103, Issue 2, 2011, Pages 110-115

  Cao, Weiguo ^a   Yang, Weiping ^a   Li, Hao ^a   Lou, Guying ^a   Jiang, Jinsong ^a   Geng, Mei ^a   Xi, Wenqi ^a   Ren, Ruobing ^a   Qu, Qing ^a   Jin, Xiaolong ^a   Zhu, Yanbo ^a   Jin, Yening ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

circulating tumor cells; gastric cancer; survivin

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; MESSENGER RNA; OXALIPLATIN; SURVIVIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TISSUE DIFFERENTIATION; TUMOR CELL;

ADULT; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79251508018     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21777     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Greene FL, Sobin LH:, The TNM system: Our language for cancer care. J Surg Oncol 2002; 80: 119-120.
3. Aurello P, D'Angelo F, Rossi S, et al.: Classification of lymph node metastases from gastric cancer: Comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg 2007; 73: 359-366.
4. Averbach AM, Jacquet P:, Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996; 83: 726-733.
5. Marrelli D, De Stefano A, de Manzoni G, et al.: Prediction of recurrence after radical surgery for gastric cancer: A scoring system obtained from a prospective multicenter study. Ann Surg 2005; 241: 247-255.
6. Kolev Y, Uetake H, Takagi Y, et al.: Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: Association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol 2008; 15: 2336-2344.
7. Bertazza L, Mocellin S, Nitti D:, Circulating tumor cells in solid cancer: Tumor marker of clinical relevance ? Curr Oncol Rep 2008; 10: 137-146.
8. Vogel I, Kalthoff H:, Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 2001; 439: 109-117.
9. Huang P, Wang J, Guo Y, et al.: Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 2003; 129: 192-198.
10. Fujita Y, Terashima M, Hoshino Y, et al.: Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer. Gastric Cancer 2006; 9: 308-314.
11. Ishigami S, Sakamoto A, Uenosono Y, et al.: Carcinoembryonic antigen messenger RNA expression in blood can predict relapse in gastric cancer. J Surg Res 2008; 148: 205-209.
12. Cao M, Yie SM, Wu SM, et al.: Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clin Exp Metastasis 2009; 26: 751-758.
13. Ambrosini G, Adida C, Altieri DC:, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921.
14. Li F:, Role of survivin and its splice variants in tumorigenesis. Br J Cancer 2005; 92: 212-216.
15. Liang QL, Wang BR, Li GH:, DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters. J Zhejiang Univ Sci B 2009; 10: 675-682.
16. Stanilov N, Miteva L, Mintchev N, et al.: High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma. Int J Colorectal Dis 2009; 24: 151-157.
17. Chen YQ, Zhao CL, Li W:, Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer. J Exp Clin Cancer Res 2009; 28: 29.
18. Chen P, Li J, Ge LP, et al.: Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients. Respirology 2010; 15: 501-509.
19. Shen C, Hu L, Xia L, et al.: The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR. Clin Biochem 2009; 42: 194-200.
20. Dalal KM, Woo Y, Kelly K, et al.: Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction. Gastric Cancer 2008; 11: 206-213.
21. Yie SM, Lou B, Ye SR, et al.: Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 2008; 15: 3073-3082.
22. Bertazza L, Mocellin S, Marchet A, et al.: Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med 2009; 7: 111.
23. Sobin LH, Fleming ID:, TNM Classification of malignant tumours, fifth edition (1997) Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804.
24. Hemilton SR, Aaltonen LA:, Tumors of the digestive system in WHO classification of tumors. Lyon: IRAC Press; 2000.
25. Yie SM, Luo B, Ye NY, et al.: Detection of survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Clin Exp Metastasis 2006; 23: 279-289.
26. Yie SM, Lou B, Ye SR, et al.: Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Lung Cancer 2009; 63: 284-290.
27. Hanley JA:, Receiver operating characteristic (ROC) methodology: The state of the art. Crit Rev Diagn Imaging 1989; 29: 307-335.
28. Fondevila C, Metges JP, Fuster J, et al.: p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 2004; 90: 206-215.
29. Tsuburaya A, Noguchi Y, Yoshikawa T, et al.: An anti-apoptosis gene, survivin and telomerase expression in gastric cancer. Hepatogastroenterology 2002; 49: 1150-1152.
30. Wang ZN, Xu HM, Jiang L, et al.: Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection. World J Gastroenterol 2004; 10: 3094-3098.
31. Wang TT, Qian XP, Liu BR:, Survivin: Potential role in diagnosis, prognosis and targeted therapy of gastric cancer. World J Gastroenterol 2007; 13: 2784-2790.
32. Lee GH, Joo YE, Koh YS, et al.: Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Eur J Gastroenterol Hepatol 2006; 18: 957-963.
33. Lu CD, Altieri DC, Tanigawa N:, Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998; 58: 1808-1812.
34. Okada E, Murai Y, Matsui K, et al.: Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 2001; 163: 109-116.
35. Krieg A, Mahotka C, Krieg T, et al.: Expression of different survivin variants in gastric carcinomas: First clues to a role of survivin-2B in tumour progression. Br J Cancer 2002; 86: 737-743.
36. Yu J, Leung WK, Ebert MP, et al.: Increased expression of survivin in gastric cancer patients and in first degree relatives. Br J Cancer 2002; 87: 91-97.
37. Wakana Y, Kasuya K, Katayanagi S, et al.: Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep 2002; 9: 1213-1218.
38. Miyachi K, Sasaki K, Onodera S, et al.: Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer. Gastric Cancer 2003; 6: 217-224.
39. Meng H, Tanigawa N, Hao CY, et al.: Chemoresponse to docetaxel correlates with expression of the survivin splicing variants in patients with gastric cancer. Hepatogastroenterology 2007; 54: 1934-1940.